PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 178 filers reported holding PTC THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,821,268 | -47.7% | 304,385 | -5.0% | 0.04% | -45.5% |
| Q2 2023 | $13,031,197 | -20.7% | 320,413 | -5.6% | 0.08% | -26.0% |
| Q1 2023 | $16,441,795 | +42.1% | 339,426 | +12.0% | 0.10% | +36.8% |
| Q4 2022 | $11,571,579 | -17.3% | 303,159 | +8.8% | 0.08% | -21.6% |
| Q3 2022 | $13,990,000 | +48.2% | 278,681 | +18.2% | 0.10% | +56.5% |
| Q2 2022 | $9,442,000 | +7.2% | 235,689 | -0.1% | 0.06% | +29.2% |
| Q1 2022 | $8,807,000 | -2.0% | 236,041 | +4.6% | 0.05% | 0.0% |
| Q4 2021 | $8,991,000 | +78.1% | 225,742 | +66.4% | 0.05% | +77.8% |
| Q3 2021 | $5,048,000 | -17.4% | 135,673 | -6.2% | 0.03% | -18.2% |
| Q2 2021 | $6,112,000 | -19.5% | 144,594 | -9.8% | 0.03% | -23.3% |
| Q1 2021 | $7,592,000 | -65.0% | 160,332 | -54.9% | 0.04% | -66.4% |
| Q4 2020 | $21,673,000 | -12.4% | 355,114 | -32.9% | 0.13% | -17.4% |
| Q3 2020 | $24,743,000 | -0.1% | 529,269 | +8.4% | 0.16% | -1.9% |
| Q2 2020 | $24,771,000 | +16.6% | 488,192 | +2.5% | 0.16% | +5.3% |
| Q1 2020 | $21,250,000 | -26.2% | 476,363 | -20.5% | 0.15% | +14.5% |
| Q4 2019 | $28,783,000 | +50.0% | 599,267 | +5.6% | 0.13% | +47.2% |
| Q3 2019 | $19,185,000 | -19.0% | 567,280 | +7.8% | 0.09% | -16.0% |
| Q2 2019 | $23,682,000 | +431.8% | 526,260 | +344.8% | 0.11% | +430.0% |
| Q1 2019 | $4,453,000 | +11.2% | 118,301 | +1.4% | 0.02% | +5.3% |
| Q4 2018 | $4,004,000 | -43.0% | 116,676 | -21.9% | 0.02% | -26.9% |
| Q3 2018 | $7,026,000 | +104.7% | 149,481 | +46.9% | 0.03% | +85.7% |
| Q2 2018 | $3,432,000 | +152.0% | 101,763 | +102.2% | 0.01% | +180.0% |
| Q1 2018 | $1,362,000 | +9628.6% | 50,320 | +5019.0% | 0.01% | – |
| Q3 2016 | $14,000 | +100.0% | 983 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | +16.7% | 983 | 0.0% | 0.00% | – |
| Q1 2016 | $6,000 | -81.2% | 983 | 0.0% | 0.00% | – |
| Q4 2015 | $32,000 | +128.6% | 983 | +87.2% | 0.00% | – |
| Q3 2015 | $14,000 | -75.0% | 525 | -59.1% | 0.00% | – |
| Q3 2014 | $56,000 | +64.7% | 1,283 | 0.0% | 0.00% | – |
| Q2 2014 | $34,000 | -2.9% | 1,283 | -4.5% | 0.00% | – |
| Q1 2014 | $35,000 | -87.8% | 1,343 | -90.0% | 0.00% | -100.0% |
| Q3 2013 | $287,000 | – | 13,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 160,372 | $7,594,000 | 6.15% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 408,000 | $19,319,000 | 5.11% |
| RTW INVESTMENTS, LP | 5,293,966 | $250,669,000 | 3.91% |
| GEORGE KAISER FAMILY FOUNDATION | 72,105 | $9,925,000 | 2.07% |
| SECTORAL ASSET MANAGEMENT INC | 504,928 | $23,908,000 | 1.81% |
| Redwood Investments, LLC | 385,014 | $18,230,000 | 1.60% |
| ARMISTICE CAPITAL, LLC | 1,396,000 | $66,101,000 | 1.52% |
| Integral Health Asset Management, LLC | 100,100 | $4,740,000 | 1.35% |
| Sofinnova Investments, Inc. | 466,840 | $22,105,000 | 1.33% |
| Chubb Ltd | 8,180 | $387,000 | 1.10% |